VIVEK SUBBIAH to Neuroendocrine Tumors
This is a "connection" page, showing publications VIVEK SUBBIAH has written about Neuroendocrine Tumors.
Connection Strength
0.136
-
Lurbinectedin in patients with pretreated neuroendocrine tumours: Results from a phase II basket study. Eur J Cancer. 2022 09; 172:340-348.
Score: 0.136
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.